New Muscle Drugs Could Redefine Aging

The Anti-Aging Secret HIDDEN in Two New Muscle Drugs

Everyone’s hyped about new muscle enhancers Trevogrumab and Garetosmab (aka “the END of steroids”) — but almost nobody is talking about their true potential for longevity.
In this episode of Longevity Science News, Emmett Short breaks down:
Why muscle ≠ strength, and why that matters for aging
The risks of enhancing muscle mass too quickly in older adults
How these drugs target myostatin and Activin A — proteins that regulate muscle growth, inflammation, and even cell death
Why the TGF-Beta Superfamily may be the real key to slowing, or even reversing, aspects of aging
What this breakthrough means for the future of personalized longevity medicine

This isn’t just about building bigger muscles — it’s proof that we can selectively target proteins at the cellular level to control how our bodies age.

Watch next: Big Pharma & Longevity Lies — EXPOSED by GLP-1s
   • Big Pharma & Longevity Lies — EXPOSED by G...  

If you’re into the cutting edge of anti-aging science, subscribe and share with someone who wants to live longer, healthier, and stronger.

⏱️ Chapters:
00:00 Cold Open
01:20 Intro
04:05 Muscle Mass & Longevity
07:55 Mass vs Strength
12:10 The Biology of T&G
16:20 How They Work
22:45 The BIG Success
27:10 The Longevity Angle
32:40 Conclusion


JOIN LSN Patreon for exclusive access to news, tips and a community of like minded longevity enthusiasts: https://www.patreon.com/user?u=29506604

Don’t forget to like, subscribe, and share for more insightful videos on health, politics, and the issues that matter most to Americans today.

PRODUCTION CREDITS
⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺
Executive Producer - Keith Comito ‪@Retromancers‬
Host, Producer, Writer - ‪@emmettshort‬
Writer - ‪@ryanstout‬​